• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2002 Fiscal Year Final Research Report Summary

A study of idopathic interstitial pneumonia with transgenic mouse (HCV)

Research Project

Project/Area Number 13670617
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Respiratory organ internal medicine
Research InstitutionTeikyo University

Principal Investigator

NAKANO Junichi  Teikyo University, School of Medicine, Department of medicine, Associate Professor, 医学部, 講師 (20240707)

Co-Investigator(Kenkyū-buntansha) YAMASHITA Naomi  Teikyo University, School of Medicine, Dept of Medicine, Associate Professor, 医学部, 助教授 (20239974)
OHTA Ken  Teikyo University, School of Medicine, Dept of Medicine, Professor, 医学部, 教授 (30160500)
Project Period (FY) 2001 – 2002
Keywordspulmonary fibrosis / mouse / hepatitis C virus / transgenic / cytokine / apoptosis / IL-4 / interstitial pneumonia
Research Abstract

Pathogenesis of IPF (interstitial pulmonary fibrosis) is still unclear despite of its poor prognosis. We hypothesized that HCV, which has been recognized, as one of major pathogen of fibrous change in liver, may play a role in IIP. First, we confirmed patients with IPF have antibody against HCV in a larger population and are more frequently positive in RT-PCR to HCV as compared to controls. In this study we investigated the role of this virus in IPF using the HCV transgenic mouse. In HCV transgenic mouse significantly sever fibrous changes were observed in lung with a small amount of silica such as 8 mg. Pro-inflammatory cytokines such as IGF-1 and TGF-beta increased in the lung in response to silica in a dose dependent manner but no significant differences were observed between transgenic and non-transgenic mouse. On the other hand, HCV transgenic mouse had significantly high expression of mRNA of IL-4 and INF-gamma as compared to controls. These findings proposed that HCV might promote the progression of fibrous changes in lung in response to silica with different profiles of cytokines.

  • Research Products

    (4 results)

All Other

All Publications (4 results)

  • [Publications] J Nakano et al.: "HCV promotes fibrosis in lung via inhibition of apoptosis in murine model."in mannscript.

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] J Nakano, K Ohta et al.: "Antisense DNA of platelet derived growth factor (PDGF) suppresses murine pulmonary fibrosis with silica particles."Am J Respir Critical Care Med. 159. 71 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] J Nakano, N Yamashita, K Ohta: "HCV promotes fibrosis in lung via inhibition of apoptosis in murine model"American Journal of Respiratory Cell and Molecular Biology. (in manuscript).

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] J Nakano, K Ohta, et al.: "Antisense DNA of platelet derived growth factor (PDGF) suppresses murine pulmonary fibrosis with silica particles"Am J Respir Critical Care Med. 159. 71 (1999)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2005-04-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi